Abilify Maintena 400 mg, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension in einer Fertigspritze
7680657740011
CH-65774
Pulver
Associated product:
ABILIFY MAINTENA Depot susp inj 400 mg 1 PFS
1 / 2
Fiches Amavita / Sun Store / Coop Vitality
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Fertigspritze(n)
- Galenic form
- Pulver
- Galenic group
- Lösbar zur Einnahme
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
aripiprazolum
|
400.0 MG | Substance | Wirkstoff (Principe actif) |
|
aripiprazolum
|
400.0 MG | Substance | Wirkstoff (Principe actif) |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
aripiprazolum monohydricum
|
- | Substance | WIZUS |
|
aripiprazolum monohydricum
|
- | Substance | WIZUS |
|
carmellosum natricum
|
- | Substance | HNIDK |
|
carmellosum natricum
|
- | Substance | HNIDK |
|
mannitolum
|
- | Substance | HNIDK |
|
mannitolum
|
- | Substance | HNIDK |
|
natrii dihydrogenophosphas monohydricus
|
- | Substance | HNIDK |
|
natrii dihydrogenophosphas monohydricus
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 311.95
Specialties list
Yes
Generic
No
SL addition date:
01/05/2016
Authorization holder
Lundbeck (Schweiz) AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 65774
- Drug name
- Abilify Maintena, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension in einer Fertigspritze
- Galenic form
- PULMR
- ATC Code
- N05AX12
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 15/03/2016
- Authorization expiration date
- 31/12/9999
- IT Number
- 01.05.0.
- Domain
- Human medicine
Package details
- Description (FR)
- ABILIFY MAINTENA Depot susp inj 400 mg 1 PFS
- Description (DE)
- ABILIFY MAINTENA Depot Inj Susp 400 mg 1 PFS
- Market launch
- 15/03/2016
- Narcotic (BTM)
- No
Available generics (10)
Aripiprazol-Mepha oro, Schmelztabletten
GTIN: 7680654780010
CHF 66.80
Aripiprazol-Mepha oro, Schmelztabletten
GTIN: 7680654780041
CHF 72.40
Aripiprazol-Mepha, Tabletten
GTIN: 7680654710017
CHF 62.65
Aripiprazol-Mepha, Tabletten
GTIN: 7680654710031
CHF 151.35
Aripiprazol-Mepha, Tabletten
GTIN: 7680654710048
CHF 66.80
Aripiprazol-Mepha, Tabletten
GTIN: 7680654710062
CHF 163.30
Aripiprazol-Mepha, Tabletten
GTIN: 7680654710079
CHF 72.40
Aripiprazol-Mepha, Tabletten
GTIN: 7680654710093
CHF 179.60
Aripiprazol-Mepha, Tabletten
GTIN: 7680654710109
CHF 117.10
Aripiprazol-Mepha, Tabletten
GTIN: 7680654710123
CHF 310.10
Other package sizes (1)
None
1 FESP
GTIN: None